Scarica l'app Stockscreener
24.29
2.62%
0.62
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PFE Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Pfizer Inc Borsa (PFE) Ultime notizie
A CFO Departure. A Clinical Miss. A $43 Billion Question Mark. Should You Throw in the Towel on Pfizer Stock? - The Motley Fool
Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now - AOL.com
Is Pfizer (NYSE:PFE) Building A Stronger Cancer Portfolio? - Kalkine Media
Here's How Many Shares of Pfizer You Must Own to Get $5,000 in Yearly Dividends - Yahoo Finance
Pfizer (PFE) Wins EU Approval For Keytruda And Padcev In Bladder Cancer - simplywall.st
Pfizer Beats Ex-Worker's Whistleblower Retaliation Suit - Law360
Prevnar 20 from Pfizer Inc.broader pneumococcal cover in one syringe - Ad-hoc-news.de
Pfizer Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Price to earnings forward of Pfizer Inc. – BCS:PFECL - TradingView
Why Did Pfizer (NYSE:PFE) Gain Attention After FDA Approval? - Kalkine Media
Pfizer: Why Being Bullish Makes Sense Despite The Patent Cliff (NYSE:PFE) - Seeking Alpha
Nike Names Pfizer’s Denton as Next CFO - WSJ
Moderna Is Up 14% Today: Is It Outperforming Other Vaccine Stocks Like Merck and Pfizer? - 24/7 Wall St.
Vitiligo Market to Witness Transformational Growth Opportunities by 2034 – DelveInsight | Pfizer, Clinuvel, Inc., Clinuvel Pharma, Bioniz Therapeutics, TAGCyx Biotech - Barchart.com
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Dividend Roundup: Pfizer, AT&T, Comcast, Sysco, and more - Seeking Alpha
Pfizer (PFE) Wins New IBRANCE Use As Lung Cancer Trial Tests Its Pipeline - simplywall.st
Pfizer reaffirmed 2026 guidance after CFO exit, shares trade near recent lows - Ad-hoc-news.de
Price to sales forward of Pfizer, Inc. – NYSE:PFE - TradingView
Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh Actuals & Estimates (BMFBOVESPA:PFIZ34) - TradingView
Pfizer stock under pressure near yearly lows despite launch of new obesity study programs - Traders Union
Price to earnings forward of Pfizer Inc. – TRADEGATE:PFE - TradingView
AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026? - The Motley Fool
Pfizer Inc. Actuals & Estimates (BVC:PFE) - TradingView
Pfizer Inc. stock underperforms Thursday when compared to competitors - MarketWatch
PFE Stock Quote Price and Forecast - CNN
Antibody-Drug Conjugates: Not Quite Worked Out Yet (PFE) - Seeking Alpha
Enterprise value to revenue forward of Pfizer Inc Shs Cert Deposito Arg Repr 0.25 Shs – BCBA:PFE.B - TradingView
FDA expands Pfizer's Ibrance label for frontline maintenance in advanced breast cancer - MSN
Price to earnings forward of Pfizer Inc Shs Cert Deposito Arg Repr 0.25 Shs – BCBA:PFE.B - TradingView
Pfizer’s US Paxlovid patent fight turns on a single error - Life Sciences Intellectual Property Review
Nike Joins Alphabet, Walmart in Hiring a CFO From the Outside - Bloomberg.com
FDA Expands Pfizer's Ibrance Label For Frontline Maintenance In Advanced Breast Cancer - Benzinga
Enterprise value to EBITDA forward of Pfizer Inc Shs Cert Deposito Arg Repr 0.25 Shs – BCBA:PFE.B - TradingView
Pfizer Declares Third-Quarter 2026 Dividend - BioSpace
ANTITRUST—D. Conn.: Pfizer off the... - VitalLaw.com
Pfizer (PFE) Is Down 7.3% After Mixed Oncology Updates Reshape Its Long-Term Pipeline Narrative - Yahoo Finance
PATENT—Fed. Cir.: Pfizer Inc. prevails in coronavirus-treatment patent dispute with biotechnology company - VitalLaw.com
Pfizer Ducks Generic Drug Claims From State AGs - Law360
Nike Hires Pfizer’s Denton to Take Over for Departing CFO - The Business of Fashion
Pfizer (PFE) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
Nike lands Pfizer CFO with $7.3M ‘new hire’ cash award - CFO Dive
Pfizer declares $0.43 quarterly dividend for third quarter By Investing.com - Investing.com Canada
Pfizer Keeps Quarterly Dividend at $0.43 per Share, Payable Sept. 1, to Shareholders of Record July 24 - marketscreener.com
Pfizer Inc. Declares Quarterly Dividend for Third-Quarter of 2026, Payable on September 1, 2026 - marketscreener.com
Pfizer (PFE) Reaffirms FY 2026 Outlook Amid Leadership Change - Insider Monkey
Pfizer Inc. (PFE) Stock: FDA Clears IBRANCE for HER2+ Breast Cancer - parameter.io
Pfizer Dismissed From US States' Lawsuit on Generic Drug Price Fixing - marketscreener.com
Pfizer Inc Stock (PFE) Moved Down by 3.16% on Jun 24: A Full Analysis - TradingKey
FDA Approves Pfizer’s IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance - Business Wire
Pfizer Freed From US States’ Drug Price-Fixing Conspiracy Claims - Bloomberg Law News
Pfizer granted FDA label expansion for breast cancer drug, Ibrance - Seeking Alpha
Pfizer Gets FDA Approval for Breast Cancer Treatment - marketscreener.com
Pfizer Advances New Pediatric Pneumococcal “Catch-Up” Vaccine in Phase 3 Trial - TipRanks
Pfizer dismissed from U.S. drug price-fixing lawsuit - grafa.com
Pfizer exec to join Nike C-suite - Chain Store Age
Pfizer's Palbociclib Combination Therapy Gets FDA Approval for Certain Types of Breast Cancer - marketscreener.com
Can a Former Pfizer Executive Catalyze Nike’s Sluggish Turnaround? - Barron's
Pfizer dismissed from US states' drug price-fixing lawsuit - Yahoo Finance
Nike names former Pfizer CFO David Denton as finance chief - Yahoo! Finance Canada
Nike hires Pfizer’s Denton to take over for departing CFO - Crain's New York
Nike names Pfizer CFO David Denton to replace Matthew Friend - qz.com
Pfizer Stock Trades Flat Following Mixed Phase 3 Lung Cancer Trial Data - Benzinga
Nike hires Pfizer's David Denton to take over for departing CFO - Moneycontrol.com
3.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):